Stifel maintains Merck at 'buy' with a price target of €182.00
An analyst from Stifel maintained Merck (ETR: MRCG) at 'buy' with a price target of €182.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had 15 buy...
Strong Buy
or
Procter Gamble Health News & Analysis
-
-
Deutsche Bank maintains Merck at 'buy' with a price target of €166.00
An analyst from Deutsche Bank maintained Merck (ETR: MRCG) at 'buy' with a price target of €166.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had 15...
-
Morgan Stanley maintains Merck at 'overweight' with a price target of €185.00
An analyst from Morgan Stanley maintained Merck (ETR: MRCG) at 'overweight' with a price target of €185.00 from a prior price target of %currency%%price%. Prior to this rating, Merck...
-
Societe Generale maintains Merck at 'hold' with a price target of €167.00
An analyst from Societe Generale maintained Merck (ETR: MRCG) at 'hold' with a price target of €167.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had...
-
Morgan Stanley maintains Merck at 'overweight' with a price target of EUR198.00
An analyst from Morgan Stanley maintained Merck (ETR: MRCG) at 'overweight' with a price target of EUR198.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had...
-
HSBC maintains Merck at 'buy' with a price target of EUR185.00
An analyst from HSBC maintained Merck (ETR: MRCG) at 'buy' with a price target of EUR185.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had 13 buy ratings,...
-
Morgan Stanley maintains Merck at 'overweight' with a price target of EUR197.00
An analyst from Morgan Stanley maintained Merck (ETR: MRCG) at 'overweight' with a price target of EUR197.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had...
-
Credit Suisse maintains Merck at 'outperform' with a price target of EUR180.00
An analyst from Credit Suisse maintained Merck (ETR: MRCG) at 'outperform' with a price target of EUR180.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had...
-
Barclays maintains Merck at 'overweight' with a price target of EUR200.00
An analyst from Barclays maintained Merck (ETR: MRCG) at 'overweight' with a price target of EUR200.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had 13...
-
Deutsche Bank maintains Merck at 'buy' with a price target of EUR205.00
An analyst from Deutsche Bank maintained Merck (ETR: MRCG) at 'buy' with a price target of EUR205.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had 13 buy...
-
JPMorgan maintains Merck at 'overweight' with a price target of EUR220.00
An analyst from JPMorgan maintained Merck (ETR: MRCG) at 'overweight' with a price target of EUR220.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had 12...
-
BofA Securities maintains Merck at 'buy' with a price target of EUR205.00
An analyst from BofA Securities maintained Merck (ETR: MRCG) at 'buy' with a price target of EUR205.00. Prior to this rating, Merck had 13 buy ratings, 3 hold ratings, and 0 sell...
-
JPMorgan maintains Merck at 'overweight' with a price target of EUR225.00
An analyst from JPMorgan maintained Merck (ETR: MRCG) at 'overweight' with a price target of EUR225.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had 13...
-
Morgan Stanley maintains Merck at 'overweight' with a price target of EUR206.00
An analyst from Morgan Stanley maintained Merck (ETR: MRCG) at 'overweight' and a price target of EUR206.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had...
-
Citi maintains Merck at Neutral, PT $200.00
A Citi analyst maintained Merck (ETR: MRCG) at Neutral and a price target of $200.00. Prior to this rating, Merck had 13 buy ratings, 3 hold ratings, and 0 sell ratings. For consensus...
-
Morgan Stanley maintains Merck at Overweight, PT $210.00
A Morgan Stanley analyst maintained Merck (ETR: MRCG) at Overweight and a price target of $210.00 from a prior price target of %currency%%price%. Prior to this rating, Merck had 13 buy...
-
Merck KGaA shares slip after group warns of decline in 2023 profit
By Scott Kanowsky Investing.com -- Shares in Merck KGaA (ETR:MRCG) fell on Thursday after the German science and technology group warned that core profit will fall in 2023 due to challenges...
-
Germany's DAX index returns to bull market, rising 20% from September lows
By Geoffrey Smith Investing.com -- German stocks are back in a bull market. The benchmark DAX index rose nearly 1% on Monday after the European Commission gave Berlin permission to...
-
Merck KGaA posts Q3 sales and core profit beat
By Scott Kanowsky Investing.com -- Shares in Merck KGaA (ETR:MRCG) rose in late afternoon trading on Thursday, erasing earlier losses, after the German science and technology company...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
